Market Tracker

07/30 1:12pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

5.41
Real-Time Quote
 +0.07 / +1.31%
Today’s Change
2.62
Today|||52-Week Range
6.00
+61.01%
Year-to-Date

Today’s Trading

Previous close5.34
Today’s open5.37
Day’s range5.32 - 5.47
Volume675,707
Average volume (3 months)2,734,723
Market cap$913.6M
Dividend yield--
Data as of 12:57pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+39.25%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales--
Price/Book43.96

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...-3.85-5.61%
TBPHTheravance Biopharma...-0.08-0.27%
PTCTPTC Therapeutics Inc-0.07-0.25%
AUXLAuxilium Pharmaceuti...+0.81+4.13%
Data as of 1:11pm ET, 07/30/2014

Financials

Next reporting dateAugust 6, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts